ACE and chronic kidney disease: Currently, clinically available drugs and therapeutic measures include angiotensin-converting enzyme inhibition, angiotensin receptor blocker, optimal blood pressure control, and sodium bicarbonate for metabolic acidosis, mainly in order to delay the progression of CKD and to prevent CKD-related complications (Humphreys, 2018).